Robert J. Canter

7.3k total citations
201 papers, 4.5k citations indexed

About

Robert J. Canter is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Robert J. Canter has authored 201 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Oncology, 86 papers in Pulmonary and Respiratory Medicine and 48 papers in Immunology. Recurrent topics in Robert J. Canter's work include Sarcoma Diagnosis and Treatment (51 papers), Immune Cell Function and Interaction (35 papers) and Vascular Tumors and Angiosarcomas (25 papers). Robert J. Canter is often cited by papers focused on Sarcoma Diagnosis and Treatment (51 papers), Immune Cell Function and Interaction (35 papers) and Vascular Tumors and Angiosarcomas (25 papers). Robert J. Canter collaborates with scholars based in United States, United Kingdom and Canada. Robert J. Canter's co-authors include Richard J. Bold, William J. Murphy, Steve R. Martinez, Arta M. Monjazeb, Steven K. Grossenbacher, Robert D. Boutin, Sean J. Judge, Dariusz Borys, Leon Lenchik and Warren H. Tseng and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Robert J. Canter

192 papers receiving 4.5k citations

Peers

Countries citing papers authored by Robert J. Canter

Since Specialization

Citations

This map shows the geographic impact of Robert J. Canter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Canter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Canter more than expected).

Fields of papers citing papers by Robert J. Canter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Canter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Canter. The network helps show where Robert J. Canter may publish in the future.

Co-authorship network of co-authors of Robert J. Canter

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Canter. A scholar is included among the top collaborators of Robert J. Canter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Canter. Robert J. Canter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Myeloid Cells in the Immunosuppressive Microenvironment as Immunotargets in Osteosarcoma 2025 ·ImmunoTargets and Therapy ·(unknown), (unknown), (unknown), Jinhwan Kim, Jessica Lawrence, Robert J. Canter	2
2	What’s in a name? Memory NK cells for cancer immunotherapy 2025 ·Journal for ImmunoTherapy of Cancer ·Sean J. Judge, (unknown), William J. Murphy, Robert J. Canter	0
3	Visceral fat area and subcutaneous fat area as measures of body composition in soft tissue sarcoma 2024 ·Journal of Surgical Oncology ·(unknown), (unknown), Sean J. Judge, Arta M. Monjazeb, Steven W. Thorpe, William J. Murphy, Jing Lyu, Daiwen Chen, Cyrus Bateni, Robert J. Canter	0
4	Musculoskeletal Tumor Society Member Survey: Intra‐Operative Peripheral Margins in Soft Tissue Sarcoma 2024 ·Journal of Surgical Oncology ·(unknown), Gilda Chavez, Morgan Darrow, Robert J. Canter, R. Lor Randall, Steven W. Thorpe	0
5	Intraoperative Peripheral Frozen Margin Assessment in Soft Tissue Sarcoma 2024 ·Journal of Surgical Oncology ·(unknown), Guadalupe Chávez, Machelle Wilson, Morgan Darrow, Robert J. Canter, R. Lor Randall, Steven W. Thorpe	0
6	Suppressive effects of obesity on NK cells: is it time to incorporate obesity as a clinical variable for NK cell-based cancer immunotherapy regimens? 2024 ·Journal for ImmunoTherapy of Cancer ·Robert J. Canter, Sean J. Judge, (unknown), Daniel Yoon, William J. Murphy	3
7	Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer 2024 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), H. Harris, Sean J. Judge, Marshall Lammers, (unknown), Eric G. Johnson, (unknown), William J. Murphy, C. Titus Brown, Robert B. Rebhun, Michael S. Kent, Robert J. Canter	4
8	Genetic Screen in a Preclinical Model of Sarcoma Development Defines Drivers and Therapeutic Vulnerabilities 2024 ·Clinical Cancer Research ·Jack Freeland, (unknown), Edmond F. O’Donnell, Justin Langerman, Morgan Darrow, (unknown), (unknown), Steven W. Thorpe, Robert J. Canter, R. Lor Randall, Kathrin Plath, Kermit L. Carraway, Owen N. Witte, Thomas G. Graeber, Janai R. Carr	1
9	PD-1 signaling serves a dual role in suppressing T cell activation but also in protecting from activation-induced cell death 2023 ·The Journal of Immunology ·(unknown), Lam T. Khuat, Catherine T. Le, (unknown), (unknown), Robert J. Canter, Arta M. Monjazeb, William J. Murphy	2
10	Aging augments obesity-induced thymic involution and peripheral T cell exhaustion altering the “obesity paradox” 2023 ·Frontiers in Immunology ·(unknown), (unknown), Lam T. Khuat, Ziming Wang, (unknown), Ethan G. Aguilar, Kevin Stoffel, Sai Yendamuri, Randall J. Smith, Sarbajit Mukherjee, Joseph Barbi, Robert J. Canter, Arta M. Monjazeb, William J. Murphy	12
11	Human soft tissue sarcomas harbor an intratumoral viral microbiome which is linked with natural killer cell infiltrate and prognosis 2023 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), (unknown), Sean J. Judge, Morgan Darrow, (unknown), (unknown), Nikhil Joshi, Matthew L. Settles, Blythe Durbin‐Johnson, Alicia A. Gingrich, Arta M. Monjazeb, Janai R. Carr, (unknown), William J. Murphy, Jonathan A. Eisen, Robert J. Canter	18
12	Scrutinizing the use of contrasted chest CTs in extremity sarcoma staging and surveillance 2023 ·Journal of Surgical Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Cyrus Bateni, (unknown), Janai R. Carr, Arta M. Monjazeb, Robert J. Canter, R. Lor Randall, Steven W. Thorpe	0
13	Regulation of human and mouse bystander T cell activation responses by PD-1 2023 ·JCI Insight ·Catherine T. Le, (unknown), (unknown), Cordelia Dunai, (unknown), Lam T. Khuat, Isabel Barão, Sean J. Judge, Ethan G. Aguilar, Brendan D. Curti, Maneesh Dave, Dan L. Longo, Bruce R. Blazar, Robert J. Canter, Arta M. Monjazeb, William J. Murphy	6
14	Surgical decision-making in advanced-stage non–small cell lung cancer is influenced by more than just guidelines 2022 ·JTCVS Open ·(unknown), Albert J. Farias, (unknown), Anthony W. Kim, Sean C. Wightman, Scott M. Atay, Robert J. Canter, Elizabeth A. David	3
15	Increased efficacy of dual proinflammatory cytokine blockade on acute GVHD while maintaining GVT effects 2021 ·Blood ·Lam T. Khuat, (unknown), Cordelia Dunai, (unknown), Shyam K. More, Catherine T. Le, Chien-Chun Steven Pai, Kevin Stoffel, Emanual Maverakis, Robert J. Canter, Arta M. Monjazeb, Dan L. Longo, Mehrdad Abedi, Eun‐Ju Choi, Bruce R. Blazar, Maneesh Dave, William J. Murphy	9
16	Activation status dictates the function of unlicensed natural killer cells in mice and humans 2021 ·Blood Advances ·Ethan G. Aguilar, Cordelia Dunai, Sean J. Judge, Anthony E. Zamora, Lam T. Khuat, (unknown), (unknown), Kevin Stoffel, Maite Álvarez, Isabel Barão, Jeffrey S. Miller, Bruce R. Blazar, Patrice Chevallier, Christelle Retière, Robert J. Canter, William J. Murphy	2
17	Association of macrophage and lymphocyte infiltration with outcome in canine osteosarcoma 2018 ·Veterinary and Comparative Oncology ·Sita S. Withers, Katherine A. Skorupski, Daniel York, (unknown), Kevin Woolard, Renée Laufer Amorim, Ellen E. Sparger, Carlos O. Rodriguez, Stephen J. McSorley, Arta M. Monjazeb, William J. Murphy, Robert J. Canter, Robert B. Rebhun	37
18	Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies 2016 ·Clinical Cancer Research ·Arta M. Monjazeb, Michael S. Kent, Steven K. Grossenbacher, Christine Mall, Anthony E. Zamora, Annie Mirsoian, Mingyi Chen, Amir Kol, Stephen L. Shiao, (unknown), Julian R. Perks, William T. N. Culp, Ellen E. Sparger, Robert J. Canter, Gail D. Sckisel, William J. Murphy	91
19	Older age impacts radiotherapy-related outcomes in soft tissue sarcoma 2015 ·Journal of Surgical Research ·(unknown), Chin‐Shang Li, Arta M. Monjazeb, Dariusz Borys, Richard J. Bold, Robert J. Canter	7
20	A Synovial Sarcoma-Specific Preoperative Nomogram Supports a Survival Benefit to Ifosfamide-Based Chemotherapy and Improves Risk Stratification for Patients 2008 ·Clinical Cancer Research ·Robert J. Canter, Li-Xuan Qin, Robert G. Maki, Murray F. Brennan, Marc Ladanyi, Samuel Singer	133

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact